Article

Understanding Immunotherapy's Side Effects

Immunotherapy use continues to expand in the cancer treatment space. So, it is important that patients and caregivers understand its potential side effects.

As the use of immunotherapy continues to grow, not only in the lung cancer space, but across numerous cancer types, it is crucial that patients and caregivers understand the potential side effects that these agents might cause, said Jarushka Naidoo, MBBCh, assistant professor of oncology and attending physician at the Sidney Kimmel Cancer Center at Johns Hopkins University.

While there are some concerns about the potential side effects that a patient can experience on immunotherapy agents such as PD-1 or PD-L1 inhibitors, Naidoo also emphasized that these therapies are typically much better tolerated compared to other traditional cancer treatment modalities like chemotherapy. However, it is important for patients and caregivers to understand that these side effects may generally occur or are a direct result of immunotherapy treatment.

Related Videos
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz